Quarterly ResultApr 29, 2026, 05:27 PM
ACHC Q1 Revenue +7.6% to $828.8M; Raises FY26 Adj. EBITDA & EPS Guidance
AI Summary
Acadia Healthcare Company, Inc. announced first quarter 2026 financial results, with revenue increasing 7.6% to $828.8 million and Adjusted EBITDA rising 7.5% to $144.2 million. However, net income attributable to Acadia decreased to $0.05 per diluted share from $0.09 in the prior-year period, and Adjusted EPS also declined. The company exceeded its Adjusted EBITDA guidance and subsequently increased its full-year 2026 Adjusted EBITDA and Adjusted EPS guidance, reflecting strong patient volumes and operating efficiencies.
Key Highlights
- Q1 2026 Revenue: $828.8 million, up 7.6% from Q1 2025.
- Q1 2026 Adjusted EBITDA: $144.2 million, up 7.5% from $134.2 million in Q1 2025.
- Q1 2026 Net Income attributable to Acadia: $0.05 per diluted share, down from $0.09 in Q1 2025.
- Q1 2026 Adjusted EPS: $0.37 per diluted share, down from $0.40 in Q1 2025.
- Full Year 2026 Adjusted EBITDA guidance raised to $580-$615 million (from $575-$610 million).
- Full Year 2026 Adjusted EPS guidance raised to $1.35-$1.60 (from $1.30-$1.55).
- Added 82 newly licensed beds in Q1 2026, including 42 to existing facilities.
- Acute Inpatient Psychiatric Facilities revenue increased 14% to $471 million.